# Photronics Inc: financial statements, quarterly

PLAB · Nasdaq · CIK 810136 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/plab.md) · [Financials](/companies/plab/financials.md) · [Filings](/companies/plab/filings.md) · [Insiders](/companies/plab/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plab/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [227 d](/filings/0001140361-25-045801.md) | [216](/filings/0001140361-25-008608.md) | [217](/filings/0001140361-25-022208.md) | [211](/filings/0001140361-25-034438.md) | [223 d](/filings/0001140361-25-045801.md) | [212](/filings/0001140361-26-009004.md) | [211](/filings/0001140361-26-024915.md) | [210](/filings/0001140361-26-036138.md) | [216 d](/filings/0001140361-25-045801.md) | [225](/filings/0001140361-26-009004.md) | [210](/filings/0001140361-26-024915.md) | [216](/filings/0001140361-26-036138.md) |
| Cost of revenue | $m | [143 d](/filings/0001140361-25-045801.md) | [137](/filings/0001140361-25-008608.md) | [138](/filings/0001140361-25-022208.md) | [136](/filings/0001140361-25-034438.md) | [140 d](/filings/0001140361-25-045801.md) | [137](/filings/0001140361-26-009004.md) | [133](/filings/0001140361-26-024915.md) | [140](/filings/0001140361-26-036138.md) | [140 d](/filings/0001140361-25-045801.md) | [146](/filings/0001140361-26-009004.md) | [144](/filings/0001140361-26-024915.md) | [144](/filings/0001140361-26-036138.md) |
| Gross profit | $m | [84.9 d](/filings/0001140361-25-045801.md) | [79.3](/filings/0001140361-25-008608.md) | [79.3](/filings/0001140361-25-022208.md) | [75.1](/filings/0001140361-25-034438.md) | [82.3 d](/filings/0001140361-25-045801.md) | [75.5](/filings/0001140361-26-009004.md) | [77.9](/filings/0001140361-26-024915.md) | [70.9](/filings/0001140361-26-036138.md) | [75.5 d](/filings/0001140361-25-045801.md) | [78.7](/filings/0001140361-26-009004.md) | [65.8](/filings/0001140361-26-024915.md) | [71.7](/filings/0001140361-26-036138.md) |
| Research and development | $m | [3.4 d](/filings/0001140361-25-045801.md) | [3.4](/filings/0001140361-25-008608.md) | [4.3](/filings/0001140361-25-022208.md) | [3.6](/filings/0001140361-25-034438.md) | [5.3 d](/filings/0001140361-25-045801.md) | [4.3](/filings/0001140361-26-009004.md) | [4.1](/filings/0001140361-26-024915.md) | [4.3](/filings/0001140361-26-036138.md) | [3.2 d](/filings/0001140361-25-045801.md) | [2.6](/filings/0001140361-26-009004.md) | [2.8](/filings/0001140361-26-024915.md) | [3.7](/filings/0001140361-26-036138.md) |
| Selling, general and administrative | $m | [16.7 d](/filings/0001140361-25-045801.md) | [18.3](/filings/0001140361-25-008608.md) | [19.0](/filings/0001140361-25-022208.md) | [19.4](/filings/0001140361-25-034438.md) | [21.0 d](/filings/0001140361-25-045801.md) | [19.1](/filings/0001140361-26-009004.md) | [18.1](/filings/0001140361-26-024915.md) | [18.4](/filings/0001140361-26-036138.md) | [20.0 d](/filings/0001140361-25-045801.md) | [21.3](/filings/0001140361-26-009004.md) | [20.8](/filings/0001140361-26-024915.md) | [22.5](/filings/0001140361-26-036138.md) |
| Operating income | $m | [64.8 d](/filings/0001140361-25-045801.md) | [57.5](/filings/0001140361-25-008608.md) | [56.1](/filings/0001140361-25-022208.md) | [52.1](/filings/0001140361-25-034438.md) | [55.8 d](/filings/0001140361-25-045801.md) | [52.2](/filings/0001140361-26-009004.md) | [55.7](/filings/0001140361-26-024915.md) | [48.2](/filings/0001140361-26-036138.md) | [52.1 d](/filings/0001140361-25-045801.md) | [54.9](/filings/0001140361-26-009004.md) | [42.2](/filings/0001140361-26-024915.md) | [45.5](/filings/0001140361-26-036138.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [20.3 d](/filings/0001140361-25-045801.md) | [14.7](/filings/0001140361-25-008608.md) | [20.2](/filings/0001140361-25-022208.md) | [14.1](/filings/0001140361-25-034438.md) | [14.6 d](/filings/0001140361-25-045801.md) | [18.9](/filings/0001140361-26-009004.md) | [5.7](/filings/0001140361-26-024915.md) | [9.6](/filings/0001140361-26-036138.md) | [(2.7) d](/filings/0001140361-25-045801.md) | [14.4](/filings/0001140361-26-009004.md) | [10.6](/filings/0001140361-26-024915.md) | [11.0](/filings/0001140361-26-036138.md) |
| Net income | $m | [44.6 d](/filings/0001140361-25-045801.md) | [26.2](/filings/0001140361-25-008608.md) | [36.3](/filings/0001140361-25-022208.md) | [34.4](/filings/0001140361-25-034438.md) | [33.9 d](/filings/0001140361-25-045801.md) | [42.9](/filings/0001140361-26-009004.md) | [8.9](/filings/0001140361-26-024915.md) | [22.9](/filings/0001140361-26-036138.md) | [61.8 d](/filings/0001140361-25-045801.md) | [42.9](/filings/0001140361-26-009004.md) | [31.4](/filings/0001140361-26-024915.md) | [28.9](/filings/0001140361-26-036138.md) |
| Diluted EPS | $ per share | not reported | [0.42](/filings/0001140361-25-008608.md) | [0.58](/filings/0001140361-25-022208.md) | [0.55](/filings/0001140361-25-034438.md) | not reported | [0.68](/filings/0001140361-26-009004.md) | [0.15](/filings/0001140361-26-024915.md) | [0.39](/filings/0001140361-26-036138.md) | not reported | [0.74](/filings/0001140361-26-009004.md) | [0.54](/filings/0001140361-26-024915.md) | [0.49](/filings/0001140361-26-036138.md) |
| Basic EPS | $ per share | not reported | [0.43](/filings/0001140361-25-008608.md) | [0.59](/filings/0001140361-25-022208.md) | [0.56](/filings/0001140361-25-034438.md) | not reported | [0.69](/filings/0001140361-26-009004.md) | [0.15](/filings/0001140361-26-024915.md) | [0.40](/filings/0001140361-26-036138.md) | not reported | [0.74](/filings/0001140361-26-009004.md) | [0.54](/filings/0001140361-26-024915.md) | [0.50](/filings/0001140361-26-036138.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | FY2024 (2024-10-31) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | FY2025 (2025-10-31) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [499](/filings/0001140361-25-045801.md) | [509](/filings/0001140361-25-008608.md) | [494](/filings/0001140361-25-022208.md) | [537](/filings/0001140361-25-034438.md) | [598](/filings/0001140361-25-045801.md) | [642](/filings/0001140361-26-009004.md) | [531](/filings/0001140361-26-024915.md) | [480](/filings/0001140361-26-036138.md) | [492](/filings/0001140361-26-036138.md) | [544](/filings/0001140361-26-009004.md) | [511](/filings/0001140361-26-024915.md) | [550](/filings/0001140361-26-036138.md) |
| Current assets | $m | [785](/filings/0001140361-24-049881.md) | [808](/filings/0001140361-24-011988.md) | [844](/filings/0001140361-24-029174.md) | [893](/filings/0001140361-24-040177.md) | [931](/filings/0001140361-25-045801.md) | [921](/filings/0001140361-25-008608.md) | [856](/filings/0001140361-25-022208.md) | [872](/filings/0001140361-25-034438.md) | [890](/filings/0001140361-26-036138.md) | [946](/filings/0001140361-26-009004.md) | [944](/filings/0001140361-26-024915.md) | [975](/filings/0001140361-26-036138.md) |
| Total assets | $m | [1,526](/filings/0001140361-24-049881.md) | [1,583](/filings/0001140361-24-011988.md) | [1,603](/filings/0001140361-24-029174.md) | [1,645](/filings/0001140361-24-040177.md) | [1,712](/filings/0001140361-25-045801.md) | [1,705](/filings/0001140361-25-008608.md) | [1,703](/filings/0001140361-25-022208.md) | [1,753](/filings/0001140361-25-034438.md) | [1,805](/filings/0001140361-26-036138.md) | [1,901](/filings/0001140361-26-009004.md) | [1,931](/filings/0001140361-26-024915.md) | [1,991](/filings/0001140361-26-036138.md) |
| Current liabilities | $m | [185](/filings/0001140361-24-049881.md) | [185](/filings/0001140361-24-011988.md) | [196](/filings/0001140361-24-029174.md) | [191](/filings/0001140361-24-040177.md) | [184](/filings/0001140361-25-045801.md) | [163](/filings/0001140361-25-008608.md) | [167](/filings/0001140361-25-022208.md) | [175](/filings/0001140361-25-034438.md) | [166](/filings/0001140361-26-036138.md) | [207](/filings/0001140361-26-009004.md) | [187](/filings/0001140361-26-024915.md) | [197](/filings/0001140361-26-036138.md) |
| Total liabilities | $m | [251](/filings/0001140361-24-049881.md) | [236](/filings/0001140361-24-011988.md) | [235](/filings/0001140361-24-029174.md) | [232](/filings/0001140361-24-040177.md) | [231](/filings/0001140361-25-045801.md) | [210](/filings/0001140361-25-008608.md) | [206](/filings/0001140361-25-022208.md) | [215](/filings/0001140361-25-034438.md) | [207](/filings/0001140361-26-036138.md) | [251](/filings/0001140361-26-009004.md) | [237](/filings/0001140361-26-024915.md) | [247](/filings/0001140361-26-036138.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [975](/filings/0001140361-24-049881.md) | [1,023](/filings/0001140361-24-011988.md) | [1,035](/filings/0001140361-24-029174.md) | [1,068](/filings/0001140361-24-040177.md) | [1,121](/filings/0001140361-25-045801.md) | [1,128](/filings/0001140361-25-008608.md) | [1,101](/filings/0001140361-25-022208.md) | [1,126](/filings/0001140361-25-034438.md) | [1,174](/filings/0001140361-26-036138.md) | [1,211](/filings/0001140361-26-009004.md) | [1,241](/filings/0001140361-26-024915.md) | [1,281](/filings/0001140361-26-036138.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [107 d](/filings/0001140361-25-045801.md) | [41.5](/filings/0001140361-25-008608.md) | [76.5 d](/filings/0001140361-25-022208.md) | [75.1 d](/filings/0001140361-25-034438.md) | [68.4 d](/filings/0001140361-25-045801.md) | [78.5](/filings/0001140361-26-009004.md) | [31.5 d](/filings/0001140361-26-024915.md) | [50.1 d](/filings/0001140361-26-036138.md) | [87.8 d](/filings/0001140361-25-045801.md) | [97.3](/filings/0001140361-26-009004.md) | [47.0 d](/filings/0001140361-26-024915.md) | [76.3 d](/filings/0001140361-26-036138.md) |
| Capital expenditure | $m | [52.5 d](/filings/0001140361-25-045801.md) | [43.3](/filings/0001140361-25-008608.md) | [20.0 d](/filings/0001140361-25-022208.md) | [24.4 d](/filings/0001140361-25-034438.md) | [43.2 d](/filings/0001140361-25-045801.md) | [35.2](/filings/0001140361-26-009004.md) | [60.5 d](/filings/0001140361-26-024915.md) | [24.8 d](/filings/0001140361-26-036138.md) | [67.5 d](/filings/0001140361-25-045801.md) | [47.6](/filings/0001140361-26-009004.md) | [45.8 d](/filings/0001140361-26-024915.md) | [37.0 d](/filings/0001140361-26-036138.md) |
| Share repurchases | $m | [0.0 d](/filings/0001140361-25-045801.md) | [0.0](/filings/0001140361-25-008608.md) | [0.0 d](/filings/0001140361-25-022208.md) | [0.0 d](/filings/0001140361-25-034438.md) | [0.0 d](/filings/0001140361-25-045801.md) | [4.6](/filings/0001140361-26-009004.md) | [72.1 d](/filings/0001140361-26-024915.md) | [20.7 d](/filings/0001140361-26-036138.md) | [0.0 d](/filings/0001140361-25-045801.md) | [0.0](/filings/0001140361-26-009004.md) | [0.0 d](/filings/0001140361-26-024915.md) | [0.0 d](/filings/0001140361-26-036138.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-29) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-30) | Q1 FY2024 (2024-01-28) | Q2 FY2024 (2024-04-28) | Q3 FY2024 (2024-07-28) | Q1 FY2025 (2025-02-02) | Q2 FY2025 (2025-05-04) | Q3 FY2025 (2025-08-03) | Q1 FY2026 (2026-02-01) | Q2 FY2026 (2026-05-03) | Q3 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [61.5](/filings/0001140361-24-011988.md) | [61.5](/filings/0001140361-24-029174.md) | [62.0](/filings/0001140361-24-040177.md) | [62.3](/filings/0001140361-25-008608.md) | [62.4](/filings/0001140361-25-022208.md) | [62.4](/filings/0001140361-25-034438.md) | [62.7](/filings/0001140361-26-009004.md) | [61.0](/filings/0001140361-26-024915.md) | [58.1](/filings/0001140361-26-036138.md) | [58.4](/filings/0001140361-26-009004.md) | [58.7](/filings/0001140361-26-024915.md) | [58.7](/filings/0001140361-26-036138.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,997,167 at 2026-09-03, from the cover of the [10-Q filed 2026-09-10](/filings/0001140361-26-036138.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.